	Telomere length and oxidative stress in small-cell lung cancer: commentary on prognostic value. Biochem Med (Zagreb) Varikasuvu SR. PMID: 41399661 [PubMed - indexed for MEDLINE]
	The cancer ratio plus in the differential diagnosis of pleural effusions: a scoping review of current evidence. Biochem Med (Zagreb) Bendimrad Y, Mellah L, Snoussi M, El Bakkouri J. PMID: 41399654 [PubMed - indexed for MEDLINE]
	The Predictive Value of NLR, PLR, LMR, NPAR and D-Dimer on the Efficacy and Prognosis of First-Line Immunotherapy for Extensive-Stage Small Cell Lung Cancer. J Inflamm Res Shen Y, Wang J, Hua Q, Dong M. PMID: 41399530 [PubMed]
	Metastatic NSCLC patients in the real world in Finland. Acta Oncol Ekroos H, Hölsä O, Kreutzman A, Nikkola L, Vikkula J, Mattila R, Knuuttila A. PMID: 41399230 [PubMed - indexed for MEDLINE]
	Loffler endocarditis as an initial manifestation of lung adenocarcinoma: A case report. Medicine (Baltimore) Yao H, Chen Y, Wu C, Wang Z, Bai F. PMID: 41398896 [PubMed - indexed for MEDLINE]
	A case report of lymphoma presenting initially with tracheoesophageal fistula and literature review. Medicine (Baltimore) Lu X, Ma L, Ma L, Chen Y, Luo Y, Liu S, Cao W. PMID: 41398835 [PubMed - indexed for MEDLINE]
	Prognostic factors for poor outcomes and the predictive role of circulating tumor DNA in immunotherapy for advanced non-small cell lung cancer. Medicine (Baltimore) Zhang WQ, Huang JL, Lin DL, Xu ZD. PMID: 41398774 [PubMed - indexed for MEDLINE]
	PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial. Nat Commun Zeng L, Ruan Z, Yan H, Qin H, Zeng Z, Zou C, Huang Z, Jiang W, Dai J, Xu S, Song L, Chen Y, Zhang Y, Zeng F, Wei S, Chen S, Liu L, Xiong Y, Wang Z, Deng J, Zhang X, Sun Y, Yang D, Zhou C, Yang H, Li Y, Deng L, Xu Q, Fang C, Chen X, Wang J, Li T, Zhang G, Zhou H, Yang N, Zhang Y. PMID: 41398162 [PubMed - as supplied by publisher]
	Comparative Analysis of Radiation Exposure from CT Scan and VQ Scan in the Diagnosis of Pulmonary Embolism: An Early-Onset Cancer Risk Assessment. J Thromb Haemost Simard C, Siegal DM, Nguyen L, Le Gal G, Sutradhar R, Delluc A. PMID: 41397561 [PubMed - as supplied by publisher]
	Integrative Methylation Profiling Uncovers IL10RB Hypomethylation as a Mediator between Environmental Heavy Metal Exposure and Lung Cancer Risk. Environ Pollut Shin H, Kim C, Kim J, Kwon J, Heo M, Kim NE, Seo S, Cho YM, Hong YS, Kim JW, Kim WJ, Won S. PMID: 41397497 [PubMed - as supplied by publisher]
	Primary Pulmonary Osteosarcoma Presenting as a 1.7-cm Subpleural Nodule in a 61-Year-Old Man: A Case Report. Am J Case Rep Yang X, Zhao WG, Gao C, Lin S. PMID: 41396867 [PubMed - indexed for MEDLINE]
	A Novel Approach Using AI-vision Transformer for CT Scan Analysis for Lung Cancer Detection. J Vis Exp Alqhatani A, S A, P S P, T R M, Khan SB, Almusharraf A. PMID: 41396864 [PubMed - indexed for MEDLINE]
	A Case of Granular Cell Tumor of the Vocal Cord. J Vis Exp Liu K, Zhu X, Ma Z, Shi H, Hu Y, Xie L, Li Y. PMID: 41396861 [PubMed - indexed for MEDLINE]
	Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 study. Cancer Zhang P, Wang D, Yin S, Dong Y, Wei S, Liu F, Zhang H, Xia B, SiTu Y, Wang M, Hu Y, Liu Q, Chen L, Qiu B, Liu H. PMID: 41396721 [PubMed - indexed for MEDLINE]
	Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges. Saudi Pharm J Sakkal M, Abdelmoteleb RWA, Al Ali A, Jardan YAB, Löbenberg R, Sarfraz M. PMID: 41396464 [PubMed]
	Efficacy and Safety of Different Types of Traditional Chinese Medicine Preparations Combined with EGFR-TKIs for Patients with Non-Small Cell Lung Cancer: A Network Meta-analysis. Chin J Integr Med Zhang CC, Zhang JY, Liu Y, Wang XX, Gao DQ, Chen ZH, Liu Y, Lin HS, Li HY, Zheng JB. PMID: 41396392 [PubMed - as supplied by publisher]
	Efficacy of continuing pembrolizumab after progression on first-line treatment in stage IV non-small cell lung cancer: a prospective real-world study. Am J Cancer Res Ruan K, Lv X, Wu X, Shao J, Chen P, Sun D, Tang Y, Wang B, Ding Y, Han Z, Huang W, Wu D, Xu Y, Zheng J, Qu J, Zhou J, Zhou J. PMID: 41395281 [PubMed]
	A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD-(L)1 in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer. MedComm (2020) Li Y, Zhou J, Jiang L, Xie H, Gong Z, Wang K, Zhang Y, Li Y, Li W, Tian P. PMID: 41394962 [PubMed]
	Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects. Front Immunol Yang M, Lei X, Ren D, Qin D, Xia X. PMID: 41394878 [PubMed - indexed for MEDLINE]
	Respiratory microbiome-host interaction on lung carcinogenesis, immunity, and immunotherapy. Front Immunol Wang P, Ge C, Jing X, Han Q, Wang M, Huang M, Xiang Z. PMID: 41394872 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 154933

Page 1 of 7747



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy